Doors Open

Opening Remarks

Aji Karunan kicks off the event with a warm welcome and a quick agenda walk-through. Get ready for a day of insights, customer stories, and forward-thinking innovation shaping the future of validation.

From Digital CSV to Smart GxP – The ValGenesis Journey

Raj Narayan, ValGenesis' COO describes the journey from the beginnings of ValGenesis to the ValGenesis Smart GxP vision. Learn how we help companies digitalize the process validation lifecycle through a closed-loop approach that leverages AI to help companies accelerate time to production, achieve "right-first-time" and improve quality and compliance.

The ValGenesis Customer Experience - Journey to Value

This session will discuss how ValGenesis can help customers compress time-to-value from signature to go-live—using an outcome-based, consultative approach that drives a consistent, yet agile delivery model that allows for adaptability and speed.  Learn how our guided engagement approach allows you to define and implement your digital validation approach in alignment with your digital transformation strategy.

Data Governance : The Strategic Approach to Pharma

In the pharmaceutical industry, data governance is a strategic approach that ensures data is managed as a reliable asset, enabling compliance, innovation, and operational efficiency. It involves establishing policies, roles, and processes for data quality, security, and accessibility across the entire data lifecycle, from research and development (R&D) to commercialization. Learn how to align governance with business goals, embed controls that safeguard integrity and security, and create the transparency what regulators expect. Real-world examples show how robust governance accelerates Gxp inspection-readiness, turning data from a liability into the launchpad for trustworthy pharma AI.

AI in the Life Sciences – A Holistic Approach

Artificial intelligence is reshaping life sciences - from drug development to personalized care - but its impact hinges on responsible, enterprise-wide adoption. In a regulated environment, fragmented AI efforts fall short. This talk explores a holistic framework grounded in three pillars: data integrity, proactive regulatory alignment, and ethical stewardship. It highlights how breaking down data silos, embedding continuous validation, and maintaining human oversight can help organizations build trustworthy, audit-ready AI systems. By aligning innovation with compliance and patient trust, life sciences teams can unlock AI’s full potential - safely and sustainably.

iClean: Digitalized Cleaning Validation Programs and Beyond

Dive with Harsha into iClean’s latest features and streamlined UX/UI. Get a first look at the new Analytical Procedures module driving digital integration, higher OEE, continuous inspection readiness, and stronger product quality.

Blueprints for Pharma 4.0 Success: Lessons from the Front Lines

Moving from slide-deck vision to plant-floor execution is where Pharma 4.0 ambitions are often tested. In this session, Yogesh C. Jagtap, Principal e-Compliance Specialist at Dr. Reddy’s Laboratories, will outline a pragmatic framework, the company used to digitise validation and modernise quality oversight. Attendees will see how risk-based methodologies, simple qualification methodologies, and clear change-management steps can shorten qualification timelines and strengthen inspection readiness. Drawing on real project milestones and lessons learned, Yogesh will distil a set of adaptable “blueprints” that any life-sciences organisation can apply to advance its own Pharma 4.0 roadmap avoiding the pitfalls due to greater compliance scrutiny during regulatory audits.

The Value of a Closed Loop Process Life Cycle

In this session, Saurabh will demonstrate how integrating Chemistry, Manufacturing & Controls (CMC) development with Continued Process Verification (CPV) in a closed‑loop validation lifecycle can turn disparate data streams into a self‑improving control system for pharmaceutical production. By continuously feeding real‑time performance insights back into process design and control strategies, manufacturers can accelerate regulatory readiness, improve product robustness, and reduce lifecycle costs while meeting ICH Q8–Q12 expectations.

Speed to Market: Real-World Wins in Digital Validation

In today’s hyper-competitive pharma landscape, every week shaved off validation can translate into months of added market exclusivity. M Prabhakar Rao, Vice President IT & IS at Natco Pharma, reveals how his team accelerates product launches by digitising and standardising the entire validation document chain. He will walk through practical tactics for locking-in data integrity, enforcing template-driven consistency, and automating review cycles - turning “smart work” into a repeatable competitive edge. Real project metrics illustrate how digital validation cut approval times, reduced rework, and empowered cross-functional teams to focus on innovation instead of paperwork. Attendees will leave with a blueprint for faster, cleaner, and regulator-ready validation that puts speed to market within reach.

Closing Remarks